Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Glowbiotics is a private U.S. skincare company focused on probiotic- and prebiotic-based topical products marketed as medical-grade skincare. The brand positions itself as a pioneer in probiotic skincare and sells cleansers, hydrators, serums, pads, sunscreens, and professional treatment products aimed at acne-prone, sensitive, aging, and uneven-toned skin. Its formulations emphasize microbiome balance, inflammation reduction, skin barrier support, and the use of probiotics, prebiotics, peptides, antioxidants, acids, and retinol. The company appears to operate primarily as a commercial consumer/professional skincare brand rather than a drug-development biotech company, with products sold online and through physicians and estheticians.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Glowbiotics.